Scott W. Andersen
Impact in
- Psychiatry and Mental health top 0.5%
- Schizophrenia research and treatment
- Dementia and Cognitive Impairment Research
- Bipolar Disorder and Treatment
- Biological Psychiatry top 2%
- Tryptophan and brain disorders
Papers in
-
- Schizophrenia research and treatment 17
- Dementia and Cognitive Impairment Research 7
- Bipolar Disorder and Treatment 5
- Pharmacology 22
- Treatment of Major Depression 16
- Cholinesterase and Neurodegenerative Diseases 6
- Co-authors
- Gary D. Tollefson (7 shared papers)John R. Sims (17 shared papers)Pierre V. Trân (2 shared papers)Mark A. Mintun (10 shared papers)Cynthia Evans (8 shared papers)Alette M. Wessels (12 shared papers)Sergey Shcherbinin (7 shared papers)JonDavid Sparks (6 shared papers)
- Journals
- Alzheimer s & Dementia (15 papers)European Neuropsychopharmacology (10 papers)The Journal of Prevention of Alzheimer s Disease (5 papers)Schizophrenia Research (5 papers)Neurology (3 papers)
- Partner nations
- United StatesUnited KingdomFrance
In The Last Decade
Scott W. Andersen
63 papers receiving 3.0k citations
Scott W. Andersen's Hit Papers
Peers
Comparison fields: 5 of 108
- Psychiatry and Mental health 1.5k
- Biological Psychiatry 181
- Physiology 886
- Pharmacology 562
- Neurology 207
Countries citing papers authored by Scott W. Andersen
This map shows the geographic impact of Scott W. Andersen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott W. Andersen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott W. Andersen more than expected).
Fields of papers citing papers by Scott W. Andersen
This network shows the impact of papers produced by Scott W. Andersen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott W. Andersen. The network helps show where Scott W. Andersen may publish in the future.
Co-authors
The 25 scholars most cited alongside Scott W. Andersen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 65 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Donanemab in Early Alzheimer’s Disease Hit paper breakdown → | 2021 | 1047 |
| 2 | Double-Blind Comparison of Olanzapine Versus Risperidone in the Treatment of Schizophrenia and Other Psychotic Disorders Hit paper breakdown → | 1997 | 566 |
| 3 | 2022 | 125 | |
| 4 | 2013 | 104 | |
| 5 | 2008 | 97 | |
| 6 | 2004 | 94 | |
| 7 | 2002 | 71 | |
| 8 | 2003 | 70 | |
| 9 | 1999 | 68 | |
| 10 | 2015 | 64 | |
| 11 | 2020 | 63 | |
| 12 | Should we consider mood disturbance in schizophrenia as an important determinant of quality of life? | 1999 | 63 |
| 13 | 2000 | 57 | |
| 14 | 2018 | 55 | |
| 15 | 2003 | 55 | |
| 16 | Amyloid-Related Imaging Abnormalities With Donanemab in Early Symptomatic Alzheimer Disease Hit paper breakdown → | 2025 | 55 |
| 17 | 2005 | 38 | |
| 18 | 2015 | 37 | |
| 19 | 2015 | 30 | |
| 20 | 2021 | 24 |
About Scott W. Andersen
Scott W. Andersen is a scholar working on Psychiatry and Mental health, Pharmacology, Physiology, Economics and Econometrics and Statistics and Probability, having authored 65 papers that have together received 3.1k indexed citations. Recurring topics across this work include Schizophrenia research and treatment (17 papers), Treatment of Major Depression (16 papers), Alzheimer's disease research and treatments (14 papers), Health Systems, Economic Evaluations, Quality of Life (8 papers), Dementia and Cognitive Impairment Research (7 papers), Cholinesterase and Neurodegenerative Diseases (6 papers), Statistical Methods in Clinical Trials (6 papers) and Bipolar Disorder and Treatment (5 papers). The work is most often cited by research in Psychiatry and Mental health (1.5k citations), Biological Psychiatry (181 citations), Physiology (886 citations), Pharmacology (562 citations) and Neurology (207 citations). Scott W. Andersen has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Gary D. Tollefson, John R. Sims, Pierre V. Trân, Mark A. Mintun, Cynthia Evans, Alette M. Wessels, Sergey Shcherbinin, JonDavid Sparks, Stephen Salloway and Paul Ardayfio. Their work appears in journals such as Alzheimer s & Dementia, European Neuropsychopharmacology, The Journal of Prevention of Alzheimer s Disease, Schizophrenia Research and Neurology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.